TAMIFLU · ReferenceDiscontinued
OSELTAMIVIR PHOSPHATE EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CAPSULE · ORAL
TAMIFLU · ReferencePrescription
OSELTAMIVIR PHOSPHATE EQ 75MG BASE · CAPSULE · ORAL
TAMIFLU · ReferenceDiscontinued
OSELTAMIVIR PHOSPHATE EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CAPSULE · ORAL
2019-08-02Efficacy · Supplement 71 · standard — Label ↗AP 2018-12-12Labeling · Supplement 70 · standard — Label ↗AP 2018-04-04Labeling · Supplement 69 · standard — Letter ↗AP 2016-06-20Labeling · Supplement 68 · standard — Letter ↗AP 2014-12-15Manufacturing (CMC) · Supplement 67 · priorityAP
2014-11-26Labeling · Supplement 60 · standard — Letter ↗AP 2014-10-14Labeling · Supplement 65 · standard — Label ↗AP 2014-10-08Manufacturing (CMC) · Supplement 66 · priorityAP
2014-05-30Labeling · Supplement 64 · standard — Label ↗AP 2013-12-20Manufacturing (CMC) · Supplement 63 · priorityAP
2013-01-29Labeling · Supplement 61 · standard — Other ↗AP 2012-08-16Labeling · Supplement 59 · standard — Label ↗AP 2011-03-21Labeling · Supplement 56 · standard — Letter ↗AP 2011-02-07Labeling · Supplement 57 · 901 required — Letter ↗AP 2010-12-15Labeling · Supplement 45 · standard — Label ↗AP 2010-11-05Labeling · Supplement 55 · standard — Label ↗AP 2010-02-22Labeling · Supplement 48 · standard — Review ↗AP 2010-02-22Efficacy · Supplement 49 · priority — Review ↗AP 2008-09-25Labeling · Supplement 47 · standard — Letter ↗AP 2008-06-10Labeling · Supplement 46 · standard — Letter ↗AP 2008-05-05Manufacturing (CMC) · Supplement 43 · priority — Letter ↗AP 2008-01-17Labeling · Supplement 42 · standard — Label ↗AP 2007-12-03Manufacturing (CMC) · Supplement 44 · priority — Letter ↗AP 2007-10-05Labeling · Supplement 41 · standard — Label ↗AP 2007-07-02Manufacturing (CMC) · Supplement 40 — Letter ↗AP 2007-03-26Manufacturing (CMC) · Supplement 39 · priority — Letter ↗AP 2007-03-22Manufacturing (CMC) · Supplement 38 · priority — Letter ↗AP 2007-03-12Manufacturing (CMC) · Supplement 37 · priority — Letter ↗AP 2007-02-27Manufacturing (CMC) · Supplement 36 · priority — Letter ↗AP 2007-02-01Manufacturing (CMC) · Supplement 35 · priority — Letter ↗AP 2006-12-19Manufacturing (CMC) · Supplement 34 · priority — Letter ↗AP 2006-06-23Manufacturing (CMC) · Supplement 31 · priority — Letter ↗AP 2005-12-21Efficacy · Supplement 30 · unknown — Letter ↗AP 2005-12-01Manufacturing (CMC) · Supplement 29 · priority — Letter ↗AP 2005-10-27Labeling · Supplement 25 · standard — Letter ↗AP 2005-10-14Manufacturing (CMC) · Supplement 28 · priority — Letter ↗AP 2005-10-14Manufacturing (CMC) · Supplement 27 · priority — Letter ↗AP 2005-08-16Labeling · Supplement 26 · standard — Letter ↗AP Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.